Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
04:37pm, Thursday, 21'st Aug 2025
LOS ANGELES , Aug. 21, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Heal
The complaint alleges Hims misled investors by selling knockoff Wegovy and overstating its Novo deal, risking patient safety and future business prospects.
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).
Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term
02:53pm, Thursday, 21'st Aug 2025
The technology sector can be one of the best places to invest your money. With the digitalization trend gaining popularity and the rapid advancements taking place in artificial intelligence, the secto
Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - HIMS
10:37am, Thursday, 21'st Aug 2025
LOS ANGELES , Aug. 21, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIM
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). S
Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets
09:05am, Thursday, 21'st Aug 2025
Most investors have noticed that most stocks in the healthcare sector have declined to levels not seen in a while, making this an area of interest for those looking into the next potential upswing in
The Gross Law Firm Notifies Hims & Hers Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - HIMS
08:45am, Thursday, 21'st Aug 2025
NEW YORK , Aug. 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the c
SAN DIEGO , Aug. 21, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
06:07am, Thursday, 21'st Aug 2025
LOS ANGELES , Aug. 21, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims &
NEW ORLEANS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securi
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
04:45pm, Wednesday, 20'th Aug 2025
LOS ANGELES , Aug. 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) have oppor
NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
Hims & Hers (HIMS) Stock Lawsuits: Investors Urged to Act - Hagens Berman
03:35pm, Wednesday, 20'th Aug 2025
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Investors who lost money in Hims & Hers (NYSE: HIMS) are being urged to actively participate in a securities class action lawsuit. The lawsuit alleges
Hims & Hers Health Inc. (NYSE: HIMS) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
01:51pm, Wednesday, 20'th Aug 2025
PHILADELPHIA , Aug. 20, 2025 /PRNewswire/ -- Berger Montague , a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ("Hims &
